Prosthodontic Treatment of a Class IV ACP PDI Patient, with Langerhans Cell Histiocytosis (LCH)

1Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Langerhans cell histiocytosis (LCH) is a disease of unknown etiology with a frustrating and unpredictable course. Surviving adult patients suffering from the multisystem type of the disease present with problems in most organs. This article presents the oral rehabilitation of a 28-year-old patient, with multisystem sequelae that included the oral cavity, classifying him as a Class IV American College of Prosthodontists Prosthodontic Diagnostic Index patient. A 5-year course of treatment is analyzed, starting from merely replacing missing teeth with a removable partial denture. The second stage of prosthetic rehabilitation included replacement of the removable prosthesis with fixed partial dentures. The final and most important aspect of treatment was the 2-year follow-up, when the patient presented with no problems or adverse effects. The purpose of this presentation is to offer an insight to prosthodontic treatment possibilities for patients suffering from multisystem LCH and to show the value of a "team approach" to achieving a positive outcome. © 2011 by The American College of Prosthodontists.

Cite

CITATION STYLE

APA

Papavasiliou, G., Kamposiora, P., Sklavounou, A., & Christopoulos, P. (2011). Prosthodontic Treatment of a Class IV ACP PDI Patient, with Langerhans Cell Histiocytosis (LCH). Journal of Prosthodontics, 20(SUPPL. 2). https://doi.org/10.1111/j.1532-849X.2011.00702.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free